Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Jenny Ousbey moves from Lexington to Westminster Advisers

She takes on the role of head of health and director

- PMLiVE

Novartis kicks back against US corruption charges

Investigation ‘explodes’ with US government information request on 79,000 physicians events

Gilead Sciences

Gilead must pay just $200m for hep C patents, says jury

Merck & Co awarded a 4% royalty rate on sales of Sovaldi and Harvoni

- PMLiVE

European bioinformatics institute appoints GSK’s Dr Andrew Leach

He joins the EMBL-EBI as head of chemistry services

- PMLiVE

Former Genzyme group vice president joins Vedanta Biosciences

Dr Bruce Roberts takes up the role of chief scientific officer

Cybersecurity

Finding a cure for pharma companies

- PMLiVE

Med comms has a ‘big role to play’ in market access

HCA meeting hears communications can assist companies with the process

- PMLiVE

Norman Lamb: Health savings ‘unachievable’ under current approach

Former minister says health system's ‘existential challenge’ needs new thinking

- PMLiVE

3D printed epilepsy drug launched in the US

Aprecia’s Spritam is now available as a prescription drug

- PMLiVE

Merck & Co wins hepatitis C patent dispute with Gilead

US jury upholds claim that Sovaldi and Harvoni infringe two sofosbuvir patents

- PMLiVE

Bayer appoints Dr Michael Preuss as new comms head

He takes over from Dr Herbert Heitmann

- PMLiVE

FDA approves new drugs from Teva, Lilly and Elusys

Cinqair, Taltz and Anthim have all been given the green light in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links